首页> 外文期刊>Pediatric blood & cancer >State of the Art and Future Needs in Cytogenetic/Molecular Genetics/Arrays in childhood lymphoma: summary report of workshop at the First International Symposium on childhood and adolescent non-Hodgkin lymphoma, April 9, 2003, New York City, NY.
【24h】

State of the Art and Future Needs in Cytogenetic/Molecular Genetics/Arrays in childhood lymphoma: summary report of workshop at the First International Symposium on childhood and adolescent non-Hodgkin lymphoma, April 9, 2003, New York City, NY.

机译:儿童淋巴瘤的细胞遗传学/分子遗传学/阵列的最新技术和未来需求:2003年4月9日在纽约州纽约市召开的第一届儿童和青少年非霍奇金淋巴瘤国际研讨会研讨会的总结报告。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: A significant number of studies describe the cytogenetics and molecular genetics of adult non-Hodgkin lymphoma (NHL); however, similar knowledge is lacking regarding pediatric NHL. METHODS: A workshop to discuss the "State of the Art and Future Needs in Cytogenetic/Molecular Genetics/Arrays" in pediatric NHL was held in conjunction with the First International Symposium on Childhood and Adolescent Non-Hodgkin Lymphoma on April 9, 2003 in New York City. RESULTS: Cytogenetic characteristics of pediatric NHL include 14q11.2 rearrangements in T-cell lymphoblastic leukemia/lymphomas (LBL), ALK rearrangements in anaplastic large cell lymphomas (ALCL), and CMYC translocations in both Burkitt and Burkitt-like lymphomas (BL/BLL). Pediatric diffuse large B-cell lymphoma (DLBCL) is cytogenetically different from DLBCL in adults, suggesting a different disease in children. Microarray studies demonstrate three types of T-cell leukemia, the leukemic counterpart of LBL, that block T-cell differentiation at different stages of T-cell development, corresponding to LYL, TAL1, and HOX-expressing leukemias. ALCL cell lines have a unique expression profile compared to normal T-cells. Germinal centers of BL have CMYC expression signatures, indicating that CMYC expression is ectopic and does not reflect the physiology of the normal cell counterpart. CONCLUSIONS: Additional cytogenetic, molecular and microarray investigations of NHL in children are vital to better understand these diseases, their etiology, and differences from adult NHL. A greater understanding of pediatric NHL will lead to disease-specific and patient-individualized therapies of these diseases.
机译:背景:大量研究描述了成年非霍奇金淋巴瘤(NHL)的细胞遗传学和分子遗传学。但是,关于小儿NHL缺乏类似的知识。方法:于2003年4月9日在美国新罕布什尔州举行的第一次儿童期和青少年期非霍奇金淋巴瘤国际研讨会期间,举办了一个讨论儿科NHL“细胞遗传学/分子遗传学/阵列的最新技术和未来需求”的研讨会。约克市。结果:小儿NHL的细胞遗传学特征包括T细胞淋巴母细胞白血病/淋巴瘤(LBL)中的14q11.2重排,间变性大细胞淋巴瘤(ALCL)中的ALK重排以及Burkitt和类Burkitt样淋巴瘤(BL / BLL)中的CMYC易位)。小儿弥漫性大B细胞淋巴瘤(DLBCL)在成人方面与DLBCL在细胞遗传学上不同,表明儿童的疾病不同。微阵列研究表明,三种类型的T细胞白血病(LBL的白血病对应物)可在T细胞发育的不同阶段阻止T细胞分化,分别对应于LYL,TAL1和HOX表达白血病。与正常T细胞相比,ALCL细胞系具有独特的表达谱。 BL的生发中心具有CMYC表达特征,表明CMYC表达是异位的,并不反映正常细胞对应物的生理学。结论:儿童NHL的其他细胞遗传学,分子和微阵列研究对于更好地了解这些疾病,其病因以及与成人NHL的区别至关重要。对小儿NHL的更多了解将导致这些疾病的疾病特定和患者个体化治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号